Stay updated on Ramucirumab vs Placebo in HCC Clinical Trial
Sign up to get notified when there's something new on the Ramucirumab vs Placebo in HCC Clinical Trial page.

Latest updates to the Ramucirumab vs Placebo in HCC Clinical Trial page
- Check6 days agoChange DetectedTaiwan site entry updated from Taoyuan to Taoyuan City (Taoyuan City, Taiwan, 33305). The previous Taoyuan entry was removed, clarifying the exact city designation for the location.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page now shows an updated ClinicalTrials.gov site revision (v3.5.3) instead of the previous one (v3.5.2) in the footer.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedLocation updated from Padua, Italy, 35128 to Padova, Italy, 35128.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded the Hepatocellular Carcinoma keyword and a Genetic and Rare Diseases Information Center resource entry; updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This change updates the site version tag and does not affect study content.SummaryDifference0.0%

Stay in the know with updates to Ramucirumab vs Placebo in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ramucirumab vs Placebo in HCC Clinical Trial page.